Groene Hart Ziekenhuis — Clinical Trial Site

45 Registered trials

15 Currently recruiting

Organisation

Groene Hart Ziekenhuis

Location

Gouda, Netherlands

Identifier

ORG-100022712

Address

Bleulandweg 10, 2803 HH, Netherlands

Departments

#2913:Cardiology
#3717: Cardiology
2605:Cardiology
3717: Cardiology
Cardiologie Research
Cardiology
chirurgie
Department of Internal Medicine
Groene Hart Bleulandlocatie
Gynaecology
Hematology
Internal medicine / Oncology
Internal medicine / Oncology-Hematology
Internal medicine, Oncology/Hematology
Interne geneeskunde
Medische Oncologie
N/A
Neurology
Obstetrics & Gynecology
Oncologie
Orthopedic surgery
Pulmonology
Reproductive medicine and gynecology
Research Cardiology
Surgery
Vascular Surgery

Clinical trials at this site (45)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment Recruiting

2023-507481-43-00 Solid tumors 11 2024-06-25
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting

2025-523123-22-00 Chronic Kidney Disease 5 2026-05-07
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting

2025-522860-34-00 Chronic lymphocytic leukemia (CLL) 5 2025-12-16
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD Recruiting

2024-512091-35-01 Peripheral arterial disease 5 2025-06-17
Ulipristal versus surgery for symptomatic uterine fibroids Recruiting

2024-512602-26-00 Uterine fibroids 6 2024-12-02
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t… Recruiting

2023-510186-98-00 Venous thromboembolism 6 2024-10-23
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting

2023-506115-17-00 Metastatic Colorectal Cancer 5 2024-10-14
Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV… Recruiting

2024-516195-15-00 Advanced NSCLC 5 2024-09-10
FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting

2023-508586-33-00 multiple myeloma 5 2024-05-14
Prevention of opioid-induced constipation in patients with advanced cancer. Recruiting

2023-509462-38-00 Patients with advanced cancer. 11 2022-10-25
Treatment of chronic lymphocytic leukaemia with venetoclax and acalabrutinib in case of return of the disease after previous treatment with … Recruiting

2023-505449-18-00 Patients with relapsed CLL 4 2020-07-23
First line treatment with VeNEtoclaX and ibruTinib induction followed by obinutuzumab intenSificaTion Exclusively in CLL/SLL Patients not in… Ended

2022-502808-72-00 Chronic Lymphocytic Leukemia 4 2024-09-11
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
Aspirin to prevent cardiovascular events in patients with pneumonia or influenza Ended

2023-504553-12-01 Influenza 6 2023-12-27
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04